Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Nicotinamide Riboside and Brain Energy in Healthy Adults

Official title: The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics

Run by Massachusetts General Hospital · NCT07649161 · Data updated 2026-11-12

This study tests whether taking nicotinamide riboside by mouth for 2 weeks can change brain energy metabolism in healthy adults aged 18–65.

More Healthy Adult trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedDecember 2026
Main results expectedSeptember 2027
Study endsJanuary 2028
Registry record updatedOctober 28, 2026
Trial IDNCT07649161 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18–65 without personal or family history of mood or psychotic disorders who can safely undergo MRI and comply with the protocol.

Probably not a fit

Individuals with significant medical conditions, psychiatric histories, pregnancy, or MRI contraindications may not benefit and may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm, open-label study using high-dose nicotinamide riboside to examine in vivo brain NAD+ and NADH levels and bioenergetic function. Participants will undergo phosphorus-31 MR spectroscopy at 7 Tesla before and after two weeks of NR treatment, serving as their own controls. The primary outcome is the NAD+ to NADH ratio in the brain, with secondary measures of overall brain energy metabolism. Up to 40 medically and psychiatrically healthy adults will be enrolled after screening for eligibility and safety. Exclusions include significant medical conditions, pregnancy, MRI contraindications, and current use of most medications or supplements.

Why it matters

Potential benefit: If successful, NR could reveal a way to influence brain energy metabolism in adults without psychiatric illness.

How similar studies have gone: Other studies using NR or similar NAD+ precursors have shown measurable effects on cellular energy processes in various tissues, though this exact brain-imaging approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults (between 18 and 65 years old)
2. Without a current psychiatric diagnosis assessed by a structured psychiatric interview at the screening/consent visit
3. Without a history of a psychotic disorder and/or mood disorder among parents, siblings, or children

Exclusion Criteria:

1. Any current significant medical or neurological illness.
2. Diagnosis of diabetes mellitus (DM), uncontrolled hypertension (HTN), severe hypotension, coronary artery disease (CAD), metabolic syndrome, glaucoma, liver impairment, decreased renal function, respiratory disorders, and uncontrolled peptic ulcer disease.
3. Currently taking any other medications, including over-the-counter supplements except oral contraceptives for women and Tylenol as needed for pain or headache.
4. Currently pregnant or breastfeeding. Females of child-bearing age must be using an effective contraceptive method.
5. History of substance abuse or dependence.
6. Contraindication to MR scan (claustrophobia, cardiac pacemakers, metal clips and stents on blood vessels, artificial heart valves, artificial arms, hands, legs, etc., brain stimulator devices, implanted drug pumps, ear implants, eye implants or known metal fragments in eyes, exposure to shrapnel or metal filings, other metallic surgical hardware in vital areas, certain tattoos with metallic ink, certain transdermal patches, metal- containing IUDs)
7. Medical condition that would prevent blood draws, including current anti-coagulant or anti-aggregant therapy, tendency for abnormal scarring (e.g., keloids).
8. Difficulty in swallowing capsules.

Where it's running

  • Dauten Family Center for Bipolar Treatment Innovation
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.